Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00374088Phase 2Completed
Phase 2, randomised, double-blind trial in myocardial dysfunction comparing N-Acetylcysteine with Placebo (2 arms). Primary endpoint: Maximum Decline in Measured Cardiac Output at 24 hours. Started Feb 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00374088.